185 related articles for article (PubMed ID: 36604325)
1. External validation of an
Mori M; Deantoni C; Olivieri M; Spezi E; Chiara A; Baroni S; Picchio M; Del Vecchio A; Di Muzio NG; Fiorino C; Dell'Oca I
Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1329-1336. PubMed ID: 36604325
[TBL] [Abstract][Full Text] [Related]
2. Intrinsic radiomic expression patterns after 20 Gy demonstrate early metabolic response of oropharyngeal cancers.
Lafata KJ; Chang Y; Wang C; Mowery YM; Vergalasova I; Niedzwiecki D; Yoo DS; Liu JG; Brizel DM; Yin FF
Med Phys; 2021 Jul; 48(7):3767-3777. PubMed ID: 33959972
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of standardized uptake value and metabolic tumour volume on ¹⁸F-FDG PET/CT in oropharyngeal squamous cell carcinoma.
Kim JW; Oh JS; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Eur J Nucl Med Mol Imaging; 2015 Aug; 42(9):1353-61. PubMed ID: 26067088
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM
AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT metabolic tumor volume and total lesion glycolysis predict outcome in oropharyngeal squamous cell carcinoma.
Lim R; Eaton A; Lee NY; Setton J; Ohri N; Rao S; Wong R; Fury M; Schöder H
J Nucl Med; 2012 Oct; 53(10):1506-13. PubMed ID: 22895812
[TBL] [Abstract][Full Text] [Related]
6. FDG-PET/CT Predicts Outcome in Oropharingeal Carcinoma Patients Undergoing Intensity Modulated Radiation Therapy with Dose Escalation to FDG-avid Tumour Volumes.
Mapelli P; Broggi S; Incerti E; Alongi P; Kirienko M; Fiorino C; Dell Oca I; Fallanca F; Vanoli EG; Di Muzio NG; Gianolli L; Picchio M
Curr Radiopharm; 2017 Aug; 10(2):102-110. PubMed ID: 28412923
[TBL] [Abstract][Full Text] [Related]
7. A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers.
Niyoteka S; Seban RD; Rouhi R; Scarsbrook A; Genestie C; Classe M; Carré A; Sun R; La Greca Saint-Esteven A; Chargari C; McKenna J; McDermott G; Malinen E; Tanadini-Lang S; Guckenberger M; Guren MG; Lemanski C; Deutsch E; Robert C
Eur J Nucl Med Mol Imaging; 2023 Nov; 50(13):4010-4023. PubMed ID: 37632562
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.
Gouw ZAR; La Fontaine MD; van Kranen S; van de Kamer JB; Vogel WV; van Werkhoven E; Sonke JJ; Al-Mamgani A
Clin Nucl Med; 2019 May; 44(5):e323-e328. PubMed ID: 30889002
[TBL] [Abstract][Full Text] [Related]
9. Training and validation of a robust PET radiomic-based index to predict distant-relapse-free-survival after radio-chemotherapy for locally advanced pancreatic cancer.
Mori M; Passoni P; Incerti E; Bettinardi V; Broggi S; Reni M; Whybra P; Spezi E; Vanoli EG; Gianolli L; Picchio M; Di Muzio NG; Fiorino C
Radiother Oncol; 2020 Dec; 153():258-264. PubMed ID: 32681930
[TBL] [Abstract][Full Text] [Related]
10. Is PET Radiomics Useful to Predict Pathologic Tumor Response and Prognosis in Locally Advanced Cervical Cancer?
Collarino A; Feudo V; Pasciuto T; Florit A; Pfaehler E; de Summa M; Bizzarri N; Annunziata S; Zannoni GF; de Geus-Oei LF; Ferrandina G; Gambacorta MA; Scambia G; Boellaard R; Sala E; Rufini V; van Velden FH
J Nucl Med; 2024 Jun; 65(6):962-970. PubMed ID: 38548352
[TBL] [Abstract][Full Text] [Related]
11. Anal cancer chemoradiotherapy outcome prediction using
Rusten E; Rekstad BL; Undseth C; Klotz D; Hernes E; Guren MG; Malinen E
Br J Radiol; 2019 May; 92(1097):20181006. PubMed ID: 30810343
[TBL] [Abstract][Full Text] [Related]
12. Predictive value of quantitative
Martens RM; Koopman T; Noij DP; Pfaehler E; Übelhör C; Sharma S; Vergeer MR; Leemans CR; Hoekstra OS; Yaqub M; Zwezerijnen GJ; Heymans MW; Peeters CFW; de Bree R; de Graaf P; Castelijns JA; Boellaard R
EJNMMI Res; 2020 Sep; 10(1):102. PubMed ID: 32894373
[TBL] [Abstract][Full Text] [Related]
13. Validation that metabolic tumor volume predicts outcome in head-and-neck cancer.
Tang C; Murphy JD; Khong B; La TH; Kong C; Fischbein NJ; Colevas AD; Iagaru AH; Graves EE; Loo BW; Le QT
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1514-20. PubMed ID: 22270174
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of
Nakajo M; Takeda A; Katsuki A; Jinguji M; Ohmura K; Tani A; Sato M; Yoshiura T
Br J Radiol; 2022 Jun; 95(1134):20211050. PubMed ID: 35312337
[TBL] [Abstract][Full Text] [Related]
15. Combining the radiomic features and traditional parameters of
Chen YH; Lue KH; Chu SC; Chang BS; Wang LY; Liu DW; Liu SH; Chao YK; Chan SC
Ann Nucl Med; 2019 Sep; 33(9):657-670. PubMed ID: 31218571
[TBL] [Abstract][Full Text] [Related]
16. Improved Prognosis of Treatment Failure in Cervical Cancer with Nontumor PET/CT Radiomics.
Yusufaly TI; Zou J; Nelson TJ; Williamson CW; Simon A; Singhal M; Liu H; Wong H; Saenz CC; Mayadev J; McHale MT; Yashar CM; Eskander R; Sharabi A; Hoh CK; Obrzut S; Mell LK
J Nucl Med; 2022 Jul; 63(7):1087-1093. PubMed ID: 34711618
[TBL] [Abstract][Full Text] [Related]
17.
Li P; Wang X; Xu C; Liu C; Zheng C; Fulham MJ; Feng D; Wang L; Song S; Huang G
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1116-1126. PubMed ID: 31982990
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of semi-quantitative FDG-PET parameters in stage I non-small cell lung cancer treated with carbon-ion radiotherapy.
Shrestha S; Higuchi T; Shirai K; Tokue A; Shrestha S; Saitoh JI; Hirasawa H; Ohno T; Nakano T; Tsushima Y
Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1220-1227. PubMed ID: 31758225
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity analysis of FDG PET tumor voxel cluster radiomics and dosimetry for predicting mid-chemoradiation regional response of locally advanced lung cancer.
Duan C; Chaovalitwongse WA; Bai F; Hippe DS; Wang S; Thammasorn P; Pierce LA; Liu X; You J; Miyaoka RS; Vesselle HJ; Kinahan PE; Rengan R; Zeng J; Bowen SR
Phys Med Biol; 2020 Oct; 65(20):205007. PubMed ID: 33027064
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Moan JM; Amdal CD; Malinen E; Svestad JG; Bogsrud TV; Dale E
Radiother Oncol; 2019 Nov; 140():54-61. PubMed ID: 31177043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
